Rigetti Computing Inc vs Revolution Medicines Inc. Common Stock — how do they compare? Rigetti Computing Inc trades at $14.03 (market cap $4.72B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 8.5× Rigetti Computing Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Rigetti Computing Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rigetti Computing Inc for 35 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| RGTI | RVMD | |
|---|---|---|
Market Cap | $4.72B | $40.32B |
Volume | 17,136,381 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $56.34 | $221.15 |
52-Week Low | $12.90 | $47.50 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $4.33B | $37.02B |
Signals from Pluang's Aura AI — not financial advice
RGTI trades at $14.14, down 3.08% amid bearish technical signals despite recent quantum computing sector momentum. The company shows severe financial strain with a -1,787.4% net income margin and negative cash flow, though revenue grew from $7M to $13M year-over-year. Analyst sentiment remains strongly bullish with 85.7% buy ratings and a $21.67 consensus target, 53% above current price.
While Wall Street sees significant upside potential in RGTI's quantum computing technology, the stock faces substantial execution risks given persistent losses and cash burn. Investors must weigh the speculative growth narrative against fundamental weaknesses, with commercialization progress being the critical factor for valuation justification.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →